95 related articles for article (PubMed ID: 12377406)
1. Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk.
Hawkins GA; Mychaleckyj JC; Zheng SL; Faith DA; Kelly B; Isaacs SD; Wiley KE; Chang BL; Ewing CM; Bujnovszky P; Bleecker ER; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Genet Cytogenet; 2002 Aug; 137(1):1-7. PubMed ID: 12377406
[TBL] [Abstract][Full Text] [Related]
2. FEZ1/LZTS1 gene at 8p22 suppresses cancer cell growth and regulates mitosis.
Ishii H; Vecchione A; Murakumo Y; Baldassarre G; Numata S; Trapasso F; Alder H; Baffa R; Croce CM
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10374-9. PubMed ID: 11504921
[TBL] [Abstract][Full Text] [Related]
3. Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22.
Cabeza-Arvelaiz Y; Sepulveda JL; Lebovitz RM; Thompson TC; Chinault AC
Oncogene; 2001 Jul; 20(31):4169-79. PubMed ID: 11464283
[TBL] [Abstract][Full Text] [Related]
4. Fez1/lzts1 alterations in gastric carcinoma.
Vecchione A; Ishii H; Shiao YH; Trapasso F; Rugge M; Tamburrino JF; Murakumo Y; Alder H; Croce CM; Baffa R
Clin Cancer Res; 2001 Jun; 7(6):1546-52. PubMed ID: 11410489
[TBL] [Abstract][Full Text] [Related]
5. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
[TBL] [Abstract][Full Text] [Related]
6. Mutational analysis of PINX1 in hereditary prostate cancer.
Hawkins GA; Chang BL; Zheng SL; Isaacs SD; Wiley KE; Bleecker ER; Walsh PC; Meyers DA; Xu J; Isaacs WB
Prostate; 2004 Sep; 60(4):298-302. PubMed ID: 15264240
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the 8p candidate tumour suppressor genes DBC2 (RHOBTB2) and LZTS1 in bladder cancer.
Knowles MA; Aveyard JS; Taylor CF; Harnden P; Bass S
Cancer Lett; 2005 Jul; 225(1):121-30. PubMed ID: 15922864
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of DLC1 as a prostate cancer susceptibility gene: mutation screen and association study.
Zheng SL; Mychaleckyj JC; Hawkins GA; Isaacs SD; Wiley KE; Turner A; Chang BL; von Kap-Herr C; Carpten JD; Pettenati M; Bleecker ER; Walsh PC; Trent JM; Meyers DA; Isaacs WB; Xu J
Mutat Res; 2003 Jul; 528(1-2):45-53. PubMed ID: 12873722
[TBL] [Abstract][Full Text] [Related]
10. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function.
Zheng SL; Ju JH; Chang BL; Ortner E; Sun J; Isaacs SD; Sun J; Wiley KE; Liu W; Zemedkun M; Walsh PC; Ferretti J; Gruschus J; Isaacs WB; Gelmann EP; Xu J
Cancer Res; 2006 Jan; 66(1):69-77. PubMed ID: 16397218
[TBL] [Abstract][Full Text] [Related]
11. The FEZ1 gene at chromosome 8p22 encodes a leucine-zipper protein, and its expression is altered in multiple human tumors.
Ishii H; Baffa R; Numata SI; Murakumo Y; Rattan S; Inoue H; Mori M; Fidanza V; Alder H; Croce CM
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3928-33. PubMed ID: 10097140
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the multiple tumor suppressor genes and 12-lipoxygenase in human prostate cancer. Therapeutic implications.
Gao X; Porter AT; Honn KV
Adv Exp Med Biol; 1997; 407():41-53. PubMed ID: 9321930
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer.
Lindmark F; Jonsson BA; Bergh A; Stattin P; Zheng SL; Meyers DA; Xu J; Grönberg H
Prostate; 2004 May; 59(2):132-40. PubMed ID: 15042613
[TBL] [Abstract][Full Text] [Related]
14. Mutation and expression analysis of LZTS1 in ovarian cancer.
Arnold JM; Choong DY; Lai J; Campbell IG; Chenevix-Trench G
Cancer Lett; 2006 Feb; 233(1):151-7. PubMed ID: 15876481
[TBL] [Abstract][Full Text] [Related]
15. A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.
Chang BL; Zheng SL; Isaacs SD; Wiley KE; Turner A; Li G; Walsh PC; Meyers DA; Isaacs WB; Xu J
Cancer Res; 2004 Mar; 64(6):1997-9. PubMed ID: 15026335
[TBL] [Abstract][Full Text] [Related]
16. Mutation of the MXI1 gene in prostate cancer.
Eagle LR; Yin X; Brothman AR; Williams BJ; Atkin NB; Prochownik EV
Nat Genet; 1995 Mar; 9(3):249-55. PubMed ID: 7773287
[TBL] [Abstract][Full Text] [Related]
17. Germ-line alterations in MSR1 gene and prostate cancer risk.
Seppälä EH; Ikonen T; Autio V; Rökman A; Mononen N; Matikainen MP; Tammela TL; Schleutker J
Clin Cancer Res; 2003 Nov; 9(14):5252-6. PubMed ID: 14614006
[TBL] [Abstract][Full Text] [Related]
18. Germline genetic variants in men with prostate cancer and one or more additional cancers.
Pilié PG; Johnson AM; Hanson KL; Dayno ME; Kapron AL; Stoffel EM; Cooney KA
Cancer; 2017 Oct; 123(20):3925-3932. PubMed ID: 28657667
[TBL] [Abstract][Full Text] [Related]
19. Absence of PTEN germ-line mutations in men with a potential inherited predisposition to prostate cancer.
Cooney KA; Tsou HC; Petty EM; Miesfeldt S; Ping XL; Gruener AC; Peacocke M
Clin Cancer Res; 1999 Jun; 5(6):1387-91. PubMed ID: 10389923
[TBL] [Abstract][Full Text] [Related]
20. The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
Kuczyk MA; Serth J; Bokemeyer C; Schwede J; Herrmann R; Machtens S; Grünewald V; Höfner K; Jonas U
Oncol Rep; 1998; 5(1):213-6. PubMed ID: 9458379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
